Skip to main content

Optimi Health Corp.

corporate_fare Company Profile

Optimi Health Corp.

OPTH·NASDAQ·Life Sciences·CIK 0002027329

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances, including finished MDMA and psilocybin drug products, which it supplies directly to authorized clinics, pharmacies, clinical trials, and partners. Optimi Health Corp. produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company is also involved in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through the Amazon marketplace, distributors/brokers, and online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Optimi Health Corp. (NASDAQ:OPTH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for OPTH at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Australia Expands Psychedelic Therapy Access, Directly Benefiting Optimi Health
  • Optimi Health Achieves Highest-Purity Natural Psilocybin Extract to Date
  • Optimi Health Closes Oversubscribed US$15M Public Offering at $6.25 Per Share
  • $15M Oversubscribed Offering Fuels Optimi Health's Nasdaq Uplisting

Insider Transactions

OPTH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$4.67 +0.03% today
52-week range · as of 2026-09-23 $4 – $8.84
Market cap
$25.71M
Volume
13.9K (0.3× avg)
3-mo avg 52.1K
Live data · 2026-10-04 13:21 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed OPTH - Filings & News (Page 2)

OPTH
May 29, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Australia Expands Psychedelic Therapy Access, Directly Benefiting Optimi Health
Price at Filing: $5.07
Real-time Price: $4.67 info
Change: -$0.3962 (-8%) info
Market Cap: $25.709M info
Sentiment: Positive
View Wiseek Article
OPTH
May 26, 2026, 7:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Optimi Health Achieves Highest-Purity Natural Psilocybin Extract to Date
Price at Filing: $5.46
Real-time Price: $4.67 info
Change: -$0.790 (-14%) info
Market Cap: $25.709M info
Sentiment: Positive
View Wiseek Article
OPTH
May 21, 2026, 1:07 PM EDT
Source: TMX Newsfile
Importance Score:
7
Optimi Health Closes Oversubscribed US$15M Public Offering at $6.25 Per Share
Price at Filing: $5.04
Real-time Price: $4.67 info
Change: -$0.3699 (-7%) info
Market Cap: $25.709M info
Sentiment: Positive
View Wiseek Article
OPTH
May 20, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
$15M Oversubscribed Offering Fuels Optimi Health's Nasdaq Uplisting
Price at Filing: N/A
Real-time Price: $4.67 info
Change: Reverse Stock Split info
Market Cap: $25.709M info
Sentiment: Positive
View Wiseek Article
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets